BR112018012765A2 - composição, método para tratamento, prevenção e/ou melhora de uma afecção médica, e, dispositivo mecânico. - Google Patents

composição, método para tratamento, prevenção e/ou melhora de uma afecção médica, e, dispositivo mecânico.

Info

Publication number
BR112018012765A2
BR112018012765A2 BR112018012765A BR112018012765A BR112018012765A2 BR 112018012765 A2 BR112018012765 A2 BR 112018012765A2 BR 112018012765 A BR112018012765 A BR 112018012765A BR 112018012765 A BR112018012765 A BR 112018012765A BR 112018012765 A2 BR112018012765 A2 BR 112018012765A2
Authority
BR
Brazil
Prior art keywords
composition
ameliorating
treating
preventing
mechanical device
Prior art date
Application number
BR112018012765A
Other languages
English (en)
Inventor
JEPPESEN BENDIX Per
Original Assignee
Univ Aarhus
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Aarhus filed Critical Univ Aarhus
Publication of BR112018012765A2 publication Critical patent/BR112018012765A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/009—Inhalators using medicine packages with incorporated spraying means, e.g. aerosol cans

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Physiology (AREA)
  • Dispersion Chemistry (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

a presente invenção refere-se a uma composição que compreende uma mistura de um polímero de biguanida polimérica e um sal de alquil- e/ou dialquil oxietileno metil amônio para uso como um medicamento, em particular, para uso no tratamento, na prevenção ou na melhora de uma doença fúngica, tal como aspergilose. a presente invenção provê um método para tratamento, prevenção e/ou melhora de uma afecção médica que compreende administrar a composição da presente invenção a um ser humano ou a um animal que necessite da mesma. um dispositivo mecânico, que compreende a dita composição, é também provido.
BR112018012765A 2015-12-23 2016-12-23 composição, método para tratamento, prevenção e/ou melhora de uma afecção médica, e, dispositivo mecânico. BR112018012765A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA201570873 2015-12-23
PCT/DK2016/050467 WO2017108065A1 (en) 2015-12-23 2016-12-23 Antifungal agent

Publications (1)

Publication Number Publication Date
BR112018012765A2 true BR112018012765A2 (pt) 2018-12-04

Family

ID=59089062

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112018012765A BR112018012765A2 (pt) 2015-12-23 2016-12-23 composição, método para tratamento, prevenção e/ou melhora de uma afecção médica, e, dispositivo mecânico.

Country Status (8)

Country Link
US (1) US20190008893A1 (pt)
EP (1) EP3393518A1 (pt)
CN (1) CN108472377A (pt)
AU (1) AU2016374834A1 (pt)
BR (1) BR112018012765A2 (pt)
CA (1) CA3008930A1 (pt)
HK (1) HK1255114A1 (pt)
WO (1) WO2017108065A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3066851A1 (en) * 2017-06-13 2018-12-20 Pulmopharma Ivs Antibiotic composition for the treatment of infections with resistent microorganism
AT521124A1 (de) * 2018-03-23 2019-10-15 Bcsk Biocid Gmbh Verfahren und Zusammensetzung zur Bekämpfung von Viren der Familie Picornaviridae
US20200268734A1 (en) * 2019-02-22 2020-08-27 Bridge Pharma, Inc. Methods of treatment of respiratory disorders
US10959992B2 (en) 2019-02-22 2021-03-30 Bridge Pharma Inc. Methods of treatment of asthma and COPD
CN112176096A (zh) * 2020-11-06 2021-01-05 上海捷诺生物科技有限公司 基于多重pcr对曲霉菌分型的试剂盒及其使用方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2260308T7 (es) * 2000-09-20 2012-03-16 Lonza Ag. Agente desinfectante.
ES2554102T3 (es) * 2002-01-18 2015-12-16 Lonza Ag Agente desinfectante viricida
DK1755576T3 (da) * 2004-04-08 2011-11-07 Dermcare Vet Pty Ltd Antimikrobielle sammensætning og fremgansmåde til anvendlese deraf
DE602006013934D1 (de) * 2005-01-25 2010-06-10 Akzo Nobel Nv Verwendung einer quaternären ammoniumverbindung als hydrotrop und zusammensetzung mit der quaternären ammoniumverbindung
JP2009518300A (ja) * 2005-12-02 2009-05-07 エラン ファーマ インターナショナル リミテッド モメタゾン組成物ならびにその作製方法および使用方法
CN102947435B (zh) * 2010-03-26 2017-06-06 利奎德范尼提公司 衣物清洁剂

Also Published As

Publication number Publication date
AU2016374834A1 (en) 2018-07-05
WO2017108065A1 (en) 2017-06-29
CA3008930A1 (en) 2017-06-29
US20190008893A1 (en) 2019-01-10
EP3393518A1 (en) 2018-10-31
HK1255114A1 (zh) 2019-08-02
CN108472377A (zh) 2018-08-31

Similar Documents

Publication Publication Date Title
BR112018012765A2 (pt) composição, método para tratamento, prevenção e/ou melhora de uma afecção médica, e, dispositivo mecânico.
BR112017003546A2 (pt) amidas heterocíclicas como inibidores de rip1 quinase como medicamentos
BR112013018920A2 (pt) composições de nanopartículas, formulações destas e seus usos
BR112019008431A2 (pt) aplicação de (s)-norcetamina e sal da mesma como fármaco
BR112015027699A2 (pt) Uso de robenidina ou um sal terapeuticamente aceitável da mesma, composição farmacêutica antibacteriana e dispositivo médico
BR112016027041A8 (pt) combinações farmacêuticas para tratamento do câncer
BR112015006623A2 (pt) laquinimod e pridopidina para o tratamento de doenças neurodegenerativas
ECSP14012676A (es) Compuestos de carbamato y preparación y uso de los mismos
BR112015027282A8 (pt) formulação líquida e kit compreendendo fenfluramina, e usos da mesma no tratamento de síndrome de dravet
BR112015026006A2 (pt) métodos para o tratamento de câncer com o uso de terapia de combinação com inibidor de cinase tor
BR112016007946A2 (pt) combinação farmacêutica, usos da mesma, de plinabulina e de composição, kits ou mistura e método para tratar e/ou prevenir câncer
BR112014028633A8 (pt) tratamento de amd usando sflt-1 de aav
BR112014008789A2 (pt) prevenção e tratamento de condições oculares
BR112015007778A2 (pt) profármacos neutralizantes de vegf para o tratamento de condições oculares
BR112016027043A8 (pt) combinação, composição farmacêutica compreendendo glucocorticoide e edo-s101, kit e uso no tratamento de câncer
BR112017017448A2 (pt) métodos e composições para o tratamento de doença do olho ressecado e outros distúrbios do olho
BR112015006093A2 (pt) combinação de rasagilina e pridopidine para o tratamento de desordens neurodegenerativas, particularmente na doença de huntington
BR112014015482A2 (pt) compostos carbamato de fenila para uso no alívio ou tratamento de dor e dor neuropática
BR112019005351A2 (pt) terapia combinada com agonistas de cnp de liberação controlada
BR112017003433A2 (pt) inibidores espirocíclicos de catepsina c
BR112017022101A2 (pt) composição farmacêutica para prevenção e/ou tratamento de dermatite atópica contendo antagonista de il-31 como ingrediente ativo
AR096892A1 (es) Una combinación farmacéutica para el tratamiento del melanoma
BR112015022650A8 (pt) inibidores de quinase induzível por sal macrocíclico.
BR112014019399A2 (pt) métodos de tratamento da fibrose
BR112017006272A2 (pt) composição farmacêutica para tratar colite ulcerativa.

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]